$ABBV News Article - EPKINLY(TM) (epcoritamab-bysp
Post# of 194
(Total Views: 212)
Posted On: 05/19/2023 3:25:47 PM
$ABBV News Article - EPKINLY(TM) (epcoritamab-bysp) Approved by U.S. FDA as the First and Only Bispecific Antibody to Treat Adult Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma (DLBCL) https://marketwirenews.com/news-releases/epki...54775.html
(0)
(0)AbbVie Inc. (ABBV) Stock Research Links
My Twitter: WhyteStocks
Scroll down for more posts ▼